Evidence map›Paper›PMID 26443703›Full record

ArticleScience signaling2015

Proteostasis trumps YAP in colon cancer.

Tony Avril, Eric Chevet

Abstract readComment
PubMed Publisher
In one paragraph

Article in Science signaling, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. CIZ1 interacts with YAP and activates its transcriptional activity in hepatocellular carcinoma cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Tony AvrilOncogenesis Stress Signaling Laboratory, ER440 INSERM, Université de Rennes 1, Rennes, France. Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France.
Eric ChevetOncogenesis Stress Signaling Laboratory, ER440 INSERM, Université de Rennes 1, Rennes, France. Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France. eric.chevet@inserm.fr.
Centre Eugène Marquis · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this issue of Science Signaling, Zhang et al. find a new role for verteporfin in the control of colorectal cancer progression through the selective induction of proteotoxicity rather than through inhibition of the transcription cofactor YAP. The study further documents the potential strategy of targeting proteostasis to kill cancer cells.

Indexed as

Adaptor Proteins, Signal TransducingAdenocarcinomaAdenomaAnimalsAntineoplastic AgentsColonic NeoplasmsHumansNeoplasm ProteinsPhosphoproteinsPorphyrinsAdaptor Proteins, Signal TransducingAntineoplastic AgentsNeoplasm ProteinsPhosphoproteinsPorphyrins

Identifiers

PMID26443703
OpenAlexW2256585275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.